Neurological complications after orthotopic liver transplantation

被引:78
作者
Amodio, P.
Biancardi, A.
Montagnese, S.
Angeli, P.
Iannizzi, P.
Cillo, U.
D'Amico, D.
Gatta, A.
机构
[1] Univ Padua, Clin Med 5 & Veneto Reg Ref Ctr Hepat Dis, I-35100 Padua, Italy
[2] Univ Padua, Transplant Ctr, I-35100 Padua, Italy
关键词
encephalopathy; immunosuppressants; liver cirrhosis; liver transplantation; neurological complication; neurotoxicity; OLTx;
D O I
10.1016/j.dld.2007.05.004
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. The number of orthotopic liver transplantation performed each year is increasing due to increased safety and logistic facilities. Therefore, the importance of reducing adverse events is progressively growing, Aim. To review present knowledge on the neurological complications of orthotopic liver transplantation. Methods. The epidemiology, the clinical features and the pathophysiology of the neurological complications of orthotopic liver transplants, resulting from a systematic review of the literature in the last 25 years, are summarized. Results and conclusions. The review highlights that a relevant variety of neurological adverse events can occur in patients undergoing orthotopic liver transplantation. The knowledge of neurological complications of orthotopic liver transplantation is important for transplantation teams to reduce their prevalence and improve their management. In addition, the likelihood of neurological adverse effects provides evidence for the need of a careful cognitive and neurological work up of patients in the orthotopic liver transplantation waiting list, in order to recognize and interpret neurological dysfunction occurring after orthotopic liver transplantation. (C) 2007 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:740 / 747
页数:8
相关论文
共 104 条
[31]   Involvement of glial cells in cyclosporine-increased permeability of brain endothelial cells [J].
Dohgu, S ;
Kataoka, Y ;
Ikesue, H ;
Naito, M ;
Tsuruo, T ;
Oishi, R ;
Sawada, Y .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 2000, 20 (06) :781-786
[32]   FK506, an immunosuppressant targeting calcineurin function [J].
Dumont, FJ .
CURRENT MEDICINAL CHEMISTRY, 2000, 7 (07) :731-748
[33]  
EIDELMAN BH, 1991, TRANSPLANT P, V23, P3175
[34]  
EIDELMAN BH, 1999, GASTROENTEROL INT C, V12, P128
[35]   SEIZURES AFTER LIVER-TRANSPLANTATION - A CLINICOPATHOLOGIC STUDY [J].
ESTOL, CJ ;
LOPEZ, O ;
BRENNER, RP ;
MARTINEZ, AJ .
NEUROLOGY, 1989, 39 (10) :1297-1301
[36]   EPIDURAL LIPOMATOSIS IN STEROID-TREATED PATIENTS [J].
FESSLER, RG ;
JOHNSON, DL ;
BROWN, FD ;
ERICKSON, RK ;
REID, SA ;
KRANZLER, L .
SPINE, 1992, 17 (02) :183-188
[37]   Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation [J].
Forgacs, B ;
Merhav, HJ ;
Lappin, J ;
Mieles, L .
TRANSPLANTATION PROCEEDINGS, 2005, 37 (04) :1912-1914
[38]   Central pontine myelinolysis and cyclosporine neurotoxicity following liver transplantation [J].
Fryer, JP ;
Fortier, MV ;
Metrakos, P ;
Verran, DJ ;
Asfar, SK ;
Pelz, DM ;
Wall, WJ ;
Grant, DR ;
Ghent, CN .
TRANSPLANTATION, 1996, 61 (04) :658-661
[39]   Immunosuppression in liver transplantation beyond calcineurin inhibitors [J].
Fung, J ;
Kelly, D ;
Kadry, Z ;
Patel-Tom, K ;
Eghtesad, B .
LIVER TRANSPLANTATION, 2005, 11 (03) :267-280
[40]  
GABRIEL A, 1993, TRANSPLANT P, V25, P1811